ArticleSultan Qaboos University medical journal2024

Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus: An open-label comparative study.

Vikram Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.